EVgo, Inc. Class A EVGO 深 沪
交易中 05-15 10:50:17 美东时间
1.915
-0.025
-1.29%
华盛通- 最 高1.94
- 今 开1.90
- 成交量 71.81万股
- 最 低 1.86
- 昨 收 1.94
- 总市值 6.01亿
- 52周最高 5.18
- 市盈率 静 --
- 换手率 0.23%
- 52周最低 1.64
- 委 比 -11.10%
- 总股本 3.14亿
- 历史最高 19.589
- 量 比 1.11
- 振 幅 4.12%
- 历史最低 1.64
- 每 手 1
- 风险率 0.82%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅20%！15家机构集体上调AMD目标价；Lumentum、神经分泌生物科学、伊顿公司、美国电力等获多家大行上调目标价
今日重点评级关注：Citizens：维持Avalo Therapeutics"跑赢大市"评级，目标价从52美元升至62美元；BTIG：维持Avalo Therapeutics"买入"评级，目标价从40美元升至58美元
05-07 12:37
RBC Capital Maintains Outperform on EVgo, Lowers Price Target to $3
RBC Capital analyst Christopher Dendrinos maintains EVgo (NASDAQ:EVGO) with a Outperform and lowers the price target from $4.5 to $3.
05-06 23:21
Earnings Scheduled For May 5, 2026
Companies Reporting Before The Bell • Repligen (NASDAQ:RGEN) is projected to re...
05-05 19:12
EVgo Sees Q2 Sales $75.000M-$85.000M vs $106.457M Est
EVgo is initiating second quarter 2026 guidance as follows:Total revenue of $75 - $85 millionAdjusted EBITDA of $(12.5) - $(7.5) million
05-05 19:09
EVgo Affirms FY2026 Sales Guidance of $410.000M-$470.000M vs $437.991M Est
2026 Financial GuidanceEVgo is affirming full year 2026 guidance as follows:Total revenue of $410 – $470 millionAdjusted EBITDA* of $(20) million – $20 million
05-05 19:08
Trump's Iran Ceasefire Revives Fed Cut Hopes: 15 Rate-Sensitive Stocks Rallying Wednesday
The 10-year yield fell to 4.25% on Iran ceasefire. Homebuilders, clean energy and banks lead the rally.
04-09 00:16
This Mondelez Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Wall Street analysts changed their outlook on top names. Check analyst ratings page for upgrades, downgrades, and initiations. MDLZ, EVGO, CRGY, ARE, TERN.
03-26 03:57
JP Morgan Downgrades EVgo to Neutral
JP Morgan analyst Mark Strouse downgrades EVgo (NASDAQ:EVGO) from Overweight to Neutral.
03-25 20:14
美股大行评级 | 潜在涨幅148%！瑞银、小摩等8家大行首予SOLV Energy买入评级目标价42美元；甲骨文绩前遭德银等下调目标价；京东遭巴克莱下调目标价
今日重点评级关注：Evercore ISI集团：维持Caribou Biosciences"跑赢大市"评级，目标价从11美元升至13美元；富国银行：上调uniQure评级至"超配"，目标价从15美元升至60美元
03-10 15:05
美股大行评级 | 7家上调，3家下调！CrowdStrike绩后大行评级现分歧；罗斯百货、塔吉特、Viking获多家大行上调目标价
今日重点评级关注：古根海姆：维持Dianthus Therapeutics"买入"评级，目标价从100美元升至200美元；HC Wainwright & Co.：维持Amylyx Pharmaceuticals"买入"评级，目标价从28美元升至34美元
03-05 13:56
